Neogen (NEOG) Equity Ratio (2010 - 2026)
Neogen's quarterly Equity Ratio came in at 0.63 in Q1 2026, down 96.08% year-on-year from 15.98 in Q1 2025, and little changed quarter-over-quarter from 0.63 in Q4 2025.
Neogen has reported Equity Ratio for 17 years, with the latest figure at 0.63 in Q1 2026.
- For the quarter ending Q1 2026, Equity Ratio fell 96.08% year-over-year to 0.63; the trailing twelve-month figure through Feb 2026 stood at 0.63 (down 96.08% YoY), and the FY2025 full-year result was 0.6, down 12.99% from the prior year.
- Equity Ratio for Q1 2026 stood at 0.63, roughly flat from 0.63 in the prior quarter.
- The five-year high for Equity Ratio was 15.98 in Q1 2025, with the low at 0.6 in Q2 2025.
- Average Equity Ratio over 5 years is 1.62, with a median of 0.69 recorded in 2023.
- Year-over-year, Equity Ratio soared 2227.21% in 2025 and sank 96.08% in 2026.
- Tracing NEOG's Equity Ratio over 5 years: stood at 0.68 in 2022, then advanced by 0.47% to 0.68 in 2023, then rose by 9.14% to 0.75 in 2024, then decreased by 16.09% to 0.63 in 2025, then slipped by 0.07% to 0.63 in 2026.
- The last three Equity Ratio figures came in at 0.63 (Q1 2026), 0.63 (Q4 2025), and 0.63 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.47 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.50 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.54 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.59 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.78 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.45 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.29 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.67 |
| 10 | Neogen | 1.94 Bn | 1.78 Bn | 99.00 Mn | 0.63 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 0.63 |
| Nov 30, 2025 | 0.63 |
| Aug 31, 2025 | 0.63 |
| May 31, 2025 | 0.60 |
| Feb 28, 2025 | 15.98 |
| Nov 30, 2024 | 0.75 |
| Aug 31, 2024 | 0.77 |
| May 31, 2024 | 0.69 |
| Feb 29, 2024 | 0.69 |
| Nov 30, 2023 | 0.68 |
| Aug 31, 2023 | 0.69 |
| May 31, 2023 | 0.69 |
| Feb 28, 2023 | 0.69 |
| Nov 30, 2022 | 0.68 |
| Aug 31, 2022 | 0.90 |
| May 31, 2022 | 0.89 |
| Feb 28, 2022 | 0.89 |
| Nov 30, 2021 | 0.89 |
| Aug 31, 2021 | 0.92 |
| May 31, 2021 | 0.91 |
| Feb 28, 2021 | 0.92 |
| Nov 30, 2020 | 0.92 |
| Aug 31, 2020 | 0.91 |
| May 31, 2020 | 0.91 |
| Feb 29, 2020 | 2.17 |
| Nov 30, 2019 | 0.92 |
| Aug 31, 2019 | 0.92 |
| May 31, 2019 | 0.92 |
| Feb 28, 2019 | 0.92 |
| Nov 30, 2018 | 0.91 |
| Aug 31, 2018 | 0.91 |
| May 31, 2018 | 0.91 |
| Feb 28, 2018 | 0.91 |
| Nov 30, 2017 | 0.90 |
| Aug 31, 2017 | 0.89 |
| May 31, 2017 | 0.89 |
| Feb 28, 2017 | 0.89 |
| Nov 30, 2016 | 0.89 |
| Aug 31, 2016 | 0.89 |
| May 31, 2016 | 0.90 |
| Feb 29, 2016 | 0.90 |
| Nov 30, 2015 | 0.89 |
| Aug 31, 2015 | 0.89 |
| May 31, 2015 | 0.89 |
| Feb 28, 2015 | 0.89 |
| Nov 30, 2014 | 0.89 |
| Aug 31, 2014 | 0.89 |
| May 31, 2014 | 0.89 |
| Feb 28, 2014 | 0.88 |
| Nov 30, 2013 | 0.88 |
| Aug 31, 2013 | 0.88 |
| May 31, 2013 | 0.89 |
| Feb 28, 2013 | 0.87 |
| Nov 30, 2012 | 0.88 |
| Aug 31, 2012 | 0.88 |
| May 31, 2012 | 0.87 |
| Feb 29, 2012 | 0.87 |
| Nov 30, 2011 | 0.87 |
| Aug 31, 2011 | 0.86 |
| May 31, 2011 | 0.86 |
| May 31, 2010 | 0.85 |